Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-CD3 antibodies for type 1 diabetes: beyond expectations.

× No keyword cloud information.

29 in total

1. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.

Authors: Tatiana Takiishi; Hannelie Korf; Tom L Van Belle; Sofie Robert; Fabio A Grieco; Silvia Caluwaerts; Letizia Galleri; Isabella Spagnuolo; Lothar Steidler; Karolien Van Huynegem; Pieter Demetter; Clive Wasserfall; Mark A Atkinson; Francesco Dotta; Pieter Rottiers; Conny Gysemans; Chantal Mathieu
Journal: J Clin Invest Date: 2012-04-09 Impact factor: 14.808

2. Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?

Authors: Li Li; Junko Nishio; André van Maurik; Diane Mathis; Christophe Benoist
Journal: J Immunol Date: 2013-08-28 Impact factor: 5.422

Review 3. Stem cell educator therapy and induction of immune balance.

Authors: Yong Zhao
Journal: Curr Diab Rep Date: 2012-10 Impact factor: 4.810

Review 4. Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

Authors: John P Driver; Yi-Guang Chen; Clayton E Mathews
Journal: Rev Diabet Stud Date: 2012-12-28

5. Th17 cells in Type 1 diabetes: a future perspective.

Authors: Laura A Solt; Thomas P Burris
Journal: Diabetes Manag (Lond) Date: 2015-07

Review 6. Regulatory T Cells: Central Concepts from Ontogeny to Therapy.

Authors: Bernard Khor
Journal: Transfus Med Rev Date: 2016-07-26

Review 7. Clinical immunologic interventions for the treatment of type 1 diabetes.

Authors: Lucienne Chatenoud; Katharina Warncke; Anette-G Ziegler
Journal: Cold Spring Harb Perspect Med Date: 2012-08-01 Impact factor: 6.915

8. Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic Mice.

Authors: William M Hanes; Peder S Olofsson; Kevin Kwan; LaQueta K Hudson; Sangeeta S Chavan; Valentin A Pavlov; Kevin J Tracey
Journal: Mol Med Date: 2015-08-17 Impact factor: 6.354

Review 9. Type 1 diabetes.

Authors: Mark A Atkinson; George S Eisenbarth; Aaron W Michels
Journal: Lancet Date: 2013-07-26 Impact factor: 79.321

10. Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.

Authors: Anne Jörns; Muharrem Akin; Tanja Arndt; Taivankhuu Terbish; Andreas Meyer Zu Vilsendorf; Dirk Wedekind; Hans-Jürgen Hedrich; Sigurd Lenzen
Journal: J Mol Med (Berl) Date: 2014-03-07 Impact factor: 4.599